• All
  • Products
  • News
  • Manuals
  • Instruments
  • About us
    Hangzhou Clongene Biotech Co., Ltd.

    Hangzhou Clongene Biotech Co., Ltd. is a national high-tech enterprise based in Hangzhou, China. We have grown and evolved in biological raw materials and in-vitro diagnostics(IVD) industries over the last 18 years. Our main products have expended from immuno-based rapid tests to molecular, Immunofluorescence, and CLIA diagnostics through the continuous technological innovations, as well as CRO&CDMO services are included.  

    Congratulations! Clongene COVID-19 Antigen Rapid Tests have passed SARS-CoV-2 variants validation by TGA
    The TGA is reviewing all COVID-19-specific laboratory antigen tests and rapid antigen tests (RATs), including point-of-care and self-tests, included in the Australian Register of Therapeutic Goods (ARTG). The purpose of the review is to determine if tests have been impacted ...
    2022 AACC ended successfully
    July 28, 2022, AACC ended successfully in Chicago which can function like a lens to focus our attention on emerging science and clinical developments that are of contemporary importance.Clongene brought main products, such as infectious diseases, drugs of abuse, COVID-19 Ant...
    Clungene COVID-19 Antigen Rapid Test has obtained CE certification
    In February 2022, CLUNGENE®COVID-19 Antigen Rapid Test for self-testing manufactured by Clongene has obtained the CE certification in EU. Our self-testing product can be sold in the European Union and other countries that recognize the CE certification.CLUNGENE®COVID-19 Anti...